Compared to patients treated for diabetes with a non-GLP-1 medication, GLP-1 use was associated with 14% reduced risk of developing any substance use disorder
Gonzlez-Molina V, Mart-Pineda A, Gonzlez N
Back Eng, J, Kleinman, WA, Singh, L, et al (April 1992) 'Isolation and characterisation of Exendin-4, an Exendin-3 analogue, from heloderma suspectum venom', The Journal of Biological Chemistry , 267/11, 7402-06
The Precision Peptide Genetic Test maps 14 pathways and 150+ genetic insights to reveal your individual peptide sensitivities, including GLP1R and GIPR variants
Effervescent or Easy-to-Consume Format Enhances bioavailability and ensures hassle-free use